Beste redactie,
Cochlear Ltd, wereldmarktleider op het gebied van innovatieve implanteerbare hooroplossingen voor doven en slechthorenden, en NXP Semiconductors kondigen vandaag een samenwerking aan met betrekking tot het ontwerp en de productie van chip devices voor Cochlear’s nieuwe generatie implanteerbare hooroplossingen. In onderstaand Engels persbericht vind u meer informatie over de overeenkomst. Als u meer informatie wilt en/of hierover met een woordvoerder van NXP wilt spreken, kunt u contact opnemen met:
Text 100
Carolien Hoogerwaard
Tel 020-5304346
E-mail:
carolien.hoogerwaard@text100.nl
Cochlear Ltd and NXP Semiconductors collaborate to enable Cochlear’s next generation Hearing Implant products
Sydney, Australia and Eindhoven, the Netherlands, October 14, 2009 - Cochlear Limited, Australian based world leader in Implantable Hearing Solutions, and NXP Semiconductors, announced today that they have signed an agreement for the design and manufacturing of IC devices for Cochlear’s future generation Implantable Hearing devices.
The agreement includes the definition, development and supply of ultra low power speech processor and wireless communication ICs to be used in Cochlear’s next generation products.
“NXP and Cochlear teams have been working together successfully for several years and our complementary strengths have been key to the development of our market leading implantable hearing solutions”, says Jan Janssen, Senior Vice President, Design & Development at Cochlear. This new agreement extends the partnership into the development and manufacturing of our wireless communication technology even further which is a key component of our future technology developments.
“We are proud to contribute our Ultra Low Power Magnetic Induction Wireless and CoolFlux™ DSP technology to enable Cochlear’s industry leading Hearing Implant solutions”, says Rene Penning de Vries, NXP CTO. “This long-term partnership with Cochlear is another example of NXP’s strategy to achieve leadership in High Performance Mixed Signal application domains. It also illustrates NXP’s engagement in the medical domain, where we target new applications such as wireless (implanted) sensors, medical body area networks and personal healthcare devices.”
About Cochlear Limited
Cochlear is the global leader in implantable hearing solutions for the hearing impaired. The Cochlear global headquarters and principal manufacturing facility is in Australia, with additional manufacturing facilities in Sweden and regional headquarters in Asia Pacific, Europe and the Americas. Cochlear has direct operations in 20 countries and more than 2,000 employees. Over
180,000 people, across more than 100 countries, now experience hearing as recipients of one of Cochlear’s hearing solutions.
Currently, Cochlear has four distinct product lines: cochlear implants, bone conduction implants, implants for electro-acoustic stimulation and implants for direct acoustic stimulation. The product lines are complementary – providing different solutions for different types of hearing loss. For further information visit
www.cochlear.com About NXP Semiconductors
NXP is a leading semiconductor company founded by Philips more than 50 years ago. Headquartered in Europe, the company has about 29,000 employees working in more than 30 countries and posted sales of USD 5.4 billion (including the Mobile & Personal business) in 2008. NXP creates semiconductors, system solutions and software that deliver better sensory experiences in TVs, set-top boxes, identification applications, mobile phones, cars and a wide range of other electronic devices. News from NXP is located at
www.nxp.com.